Skip to main content

Table 2 Relationship between SIRI and clinical variables

From: Prognostic significance of preoperative systemic inflammation response index in newly diagnosed glioblastoma patients underwent gross total resection: a propensity score matching analysis

Clinical variables

Original cohort

PSM cohort

SIRI < 1.26 (n = 177)

SIRI ≥ 1.26 (n = 114)

p value

SIRI < 1.26 (n = 98)

SIRI ≥ 1.26 (n = 98)

p value

Age at diagnosis

< 55

94

55

0.933

50

46

0.988

≥ 55

83

59

48

52

Gender

Male

96

90

< 0.001

73

74

0.177

Female

81

24

25

24

Preoperative seizure

Yes

25

15

0.83

15

13

0.974

No

152

99

83

85

KPS

≤ 80

103

80

0.396

59

64

0.959

> 80

74

34

39

34

Hemisphere

Right

74

58

0.11

43

46

0.465

Left

94

50

 

51

47

Midline or bilateral

9

6

4

5

Tumor location

Frontal lobe

70

28

0.088

32

28

0.136

Temporal lobe

29

30

16

27

Parietal lobe

20

6

12

6

Occipital lobe

6

2

1

2

Insular lobe

7

5

5

5

Other regions

45

43

32

30

Ki-67 index

< 30%

105

65

0.636

63

56

0.217

≥ 30%

72

49

35

42

IDH-1 status

Mutant

29

13

0.531

15

12

0.491

Wildtype

148

101

83

86

  1. Significant findings are expressed in bold and italic
  2. Abbreviations: KPS Karnofsky performance status, IDH-1 isocitrate dehydrogenase-1, SIRI systemic inflammation response index, NLR neutrophil to lymphocyte ratio, PSM propensity score matching